Health News Releases

  • Today December 21
June 08, 2017 10:40
22nd Century Produces Non-GMO Very Low Nicotine Tobacco
22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that the Company’s research collaboration with
June 07, 2017 18:30
Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter® with Next Generation SpHb®
Masimo (NASDAQ:MASI) announced today, in conjunction with its CE marking, the limited market release of the Spot-Check Rad-67™ Handheld Pulse CO-Oximeter®. Rad-67 offers Measure-through Motion and Low
June 07, 2017 18:00
Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.
Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection System (CPS), via de novo classificatio
June 07, 2017 11:42
The world’s first genome-based sharing platform ‘MyGenomeBox,’ to Showcase New Revolution and Life Experience on DNA App Store at CES Asia 2017
MyGenomeBox, the world’s first open genome-based sharing platform, will participate in “CES Asia 2017” to introduce their service in Asian market. CES Asia 2017 will be held from June 7 to 9 at the
June 07, 2017 10:55
AstraZeneca Presents Tagrisso(osimertinib) Data in Patients with EGFR T790M-Mutation Positive Lung Cancer and Central Nervous System Metastases
AstraZeneca today reported further evidence that Tagrisso (osimertinib), the potential new standard of care for adult patients with locally advanced or metastatic epidermal growth factor receptor (EGF
June 05, 2017 18:00
Encouraging Phase II survival data for nintedanib in malignant pleural mesothelioma presented at ASCO 2017
Boehringer Ingelheim today announced that Phase II results from LUME-Meso, a randomised, double-blind, placebo-controlled trial, have been presented as part of an Oral Abstract Session at the 2017 Ann
June 05, 2017 11:30
Masimo and Mdoloris Announce Masimo Open Connect™ (MOC) Partnership for the Root® Patient Monitoring and Connectivity Hub
Masimo (NASDAQ: MASI) and Mdoloris Medical Systems announced today a Masimo Open Connect™ (MOC) partnership for the Root® Open Architecture Patient Monitoring and Connectivity Hub, in which Mdoloris i
June 02, 2017 15:35
Lynparza (olaparib) Maintenance Treatment Offers Sustained Quality of Life alongside Improved Progression-Free Survival in Women with BRCA-Mutated Ovarian Cancer
AstraZeneca today reported new data from the Phase III SOLO-2 trial of Lynparza (olaparib) 300mg twice-daily tablet maintenance treatment showing that quality of life (QoL) is sustained alongside impr
June 02, 2017 11:45
Ferring Appoints Aaron Graff to Executive Board
Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer and made a member of the Ferring Group Executive Board, effective imme
June 01, 2017 13:50
Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.
Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.
June 01, 2017 13:35
Boston Healthcare Associates and Data Information Intelligence Announce Global Life Sciences Data Commercialization Partnership
Boston Healthcare Associates, Inc. (Boston Healthcare), a global life sciences consultancy, and Data Information Intelligence GmbH (dii) today announced a new partnership to develop and commercialize
May 30, 2017 16:35
Takeda Showcases Broadened Oncology Portfolio Through Data Presentations at Upcoming Medical Meetings
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature new clinical analyses and outcomes research during three upcoming medical meetings: the 53rd Annual Meet
May 30, 2017 13:30
World Bedwetting Day Steering Committee: New global guidelines call for more effective treatment for bedwetting, a common condition which affects 1 in 15 children[1]
The World Bedwetting Day Steering Committee (WBD-SC) has launched simplified practical guidelines to help healthcare professionals understand how best to treat bedwetting. “For decades, people thou
May 25, 2017 10:55
IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function[1]
Boehringer Ingelheim today announced the presentation of new analyses on the use of OFEV® (nintedanib) in treating idiopathic pulmonary fibrosis (IPF) at the 2017 American Thoracic Society (ATS) confe
May 24, 2017 11:50
ATS 2017 Spiriva® Respimat® improves breathing for people with asthma regardless of BMI or allergic status
Boehringer Ingelheim today announced new analyses that provide further evidence that adding tiotropium Respimat® (Spiriva® Respimat®) improved breathing across diverse patient populations who experien
May 23, 2017 15:20
LMD’s V-Sensor Set to Measure Vital Signs in India
Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that its V-Sensor and app - the only
May 23, 2017 13:25
Octapharma Underlines Strong Commitment to Haemophilia A Patients with the Publication of New Clinical Data on PK-guided Personalized Prophylaxis According to the NuPreviq Approach with Nuwiq®
Octapharma announces positive new clinical data in 66 previously treated patients (PTPs) with severe haemophilia A (HA) undergoing PK-guided personalized prophylaxis with Nuwiq® according to the NuPre
May 22, 2017 17:50
Stuart Raetzman Appointed CEO of Nestlé Skin Health
Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately. “I am very pleased that Stuart will be leading Nestlé Skin Health as CEO. Nestlé’s purpose is to enhance qu
May 22, 2017 14:55
Herbalife Nutrition Inspires Southeast Asia Member Community to be Change Agents for Healthy Active Living in the Region
Herbalife, a global nutrition company, has concluded its annual Asia Pacific Extravaganza 2017, held from May 19 to 21 in Bangkok, Thailand, to a rousing reception. As a training event organized for H
May 17, 2017 11:55
Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University
Boehringer Ingelheim and Peking University (PKU) today announced an ambitious strategic partnership with the aim of jointly advancing early science innovation across a range of areas of high medical n
May 16, 2017 17:05
Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial[1] concluding that, in the patients studied, the use of
May 16, 2017 16:45
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China
Today, Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China). The site, with the first-phase investment of more than €7
May 16, 2017 16:00
Herbalife Nutrition Urges Southeast Asia Consumers to Actively Combat Obesity with Balanced Nutrition Habits
Global nutrition company, Herbalife (NYSE:HLF), is urging Southeast Asia consumers to actively combat obesity by adopting balanced nutrition habits in everyday living. Speaking at a lunch symposium of
May 11, 2017 15:50
SERMO Unveils First Global Physician-to-Physician Drug Ratings Tool
SERMO, the largest global social network for physicians with 650,000 members worldwide, today announced the groundbreaking new “Drug Ratings” tool. Drug Ratings is the first and only global peer-to-pe
May 11, 2017 13:45
Takeda Reports FY2016 Full Year Results and Issues FY2017 Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502): Delivered substantial profit growth versus prior year · Underlying Revenue grew +6.9%, with Takeda's Growth Drivers (GI, Oncology, CNS and Eme
25 per page50 per page75 per page100 per page